Search

Search results

4262 results found

Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial.

Topriceanu, Constantin-Cristian, Christoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, Mark W Russell, Kenneth Zahka, Alexandre C Pereira, et al. 2025. “Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial.”. Circulation. Heart Failure 18 (6): e012393.

Insights from the SAFE-CLTI Study: Explore Our Findings

The SAFE-CLTI (Critical Limb-Threatening Ischemia) initiative, a collaboration between the Smith Center and FDA, investigates: Trends in site-of-service for CLTI care Disparities in access and outcomes Comparative effectiveness of endovascular strategies Patient-centered outcomes like mobility and...